Gynecologic Cancer Surgeon, Views are my own.
Heidelberg, Germany
Joined May 2013
- Tweets2K
- Following581
- Followers971
- Likes22.7K
Oliver Zivanovic retweeted
So honored to be serving as Program Co-Chair with these 2 amazing colleagues! Looking forward to seeing you at IGCS TOKYO 2027 #IGCS
Oliver Zivanovic retweeted
You know it’s love when your girlfriend lets you climb on her back so you can get a better shot at your enemies.
Oliver Zivanovic retweeted
🎙️ New #IJGCconversations episode! 🌍
How does #resource availability shape gynecologic #oncology #practice?
💬 Join @pedroramirezMD and @RParejaGineOnco to explore:
🔹 #Challenges in low- and middle-resource settings
🔹 #Insights into clinical practice
🔹 #Opportunities to advance care
🎧 Tune in ⬇️
bit.ly/4dplkdT
@HsuMd @JayrajAarthi @AndreFernandes2 @IGCSociety @ESGO_society @ENYGO_official @OncoAlert @IJGCfellows @GynMe4 @lchiv4 @annafagottimd @HousseinELHAJJ3 @AinhoaMada @Suvidyasingh20 @ohadfeld
#WeeklyPodcast #LeadArticle #IJGConline #Research #Prevention #Treatment #Diagnostic #GynCancer #GynOnc #WomenHealth #SoMe #SoMe4GynOnc
Oliver Zivanovic retweeted
We celebrated a meaningful moment in the #IJGCfamily story at the #IGCS2026 Annual Global Meeting.💖
Pedro Ramirez @pedroramirezMD presented his report as Editor-in-Chief and took us on a journey through the history, growth and achievements of our journal. A legacy shaped by vision, dedication and an extraordinary global community.
We were also thrilled to witness René Pareja @RParejaGineOnco officially receive the role of Editor-in-Chief. This is not just a transition, but the continuation of a shared mission: advancing knowledge, education, and care in gynecologic oncology.
Thank you Pedro, for your remarkable leadership and for all that you have brought to IJGC.🤩
Congratulations René, we are excited for the next chapter. 💙
@HsuMd @JayrajAarthi @AndreFernandes2 @IGCSociety @ESGO_society @ENYGO_official @OncoAlert @IJGCfellows @GynMe4 @Suvidyasingh20 @ohadfeld
Oliver Zivanovic retweeted
Dr. Baiocchi presented secondary endpoints of ALICE trial at #igcs2026. LND is done and over for endometrial carcinoma.
Oliver Zivanovic retweeted
Every study, clinical trial, and new discovery helps us improve prevention, diagnosis, treatment, and QoL for women affected by #gynecologiccancers
We recognize the researchers, clinicians, and patients whose collaboration moves care forward.
Together, research brings us closer to better outcomes for every patient. 💜
#WorldGoDay #GynecologicCancerAwarenessMonth
@pedroramirezMD @RParejaGineOnco @HsuMd @JayrajAarthi @AndreFernandes2 @IGCSociety @ESGO_society @ENYGO_official @OncoAlert @IJGCfellows @GynMe4 @Suvidyasingh20 @ohadfeld @WorldGOday
Oliver Zivanovic retweeted
We are walking (on all fours) the narrow ridge between Switzerland and Italy. Exposure was sickening and breathtaking at the same time.
Oliver Zivanovic retweeted
Breithorn Halftraverse with my son. Never thought I would have the courage to do this- but he pushed me and we came back in one piece !( thanks to our amazing mountain guide @ Markus Beck in Zermatt!!)
We are walking (on all fours) the narrow ridge between Switzerland and Italy. Exposure was sickening and breathtaking at the same time.
Breithorn Halftraverse with my son. Never thought I would have the courage to do this- but he pushed me and we came back in one piece !( thanks to our amazing mountain guide @ Markus Beck in Zermatt!!)
Oliver Zivanovic retweeted
ASCO Gynecological Cancers-
Ideal Timing for Surgical Cytoreduction in Advanced Ovarian Cancer
Goals should be treatment at dedicated high-volume centers, with infrastructure to care for these complex patients
medpagetoday.com/reading-roo… #gyncsm
Oliver Zivanovic retweeted
Correspondence: PRAME-Specific T-Cell Therapy in Advanced Pediatric Nephroblastoma nej.md/3U8jVl2
#Oncology #Pediatrics
ALT This image is a set of figures showing PRAME-specific T cells in a pediatric patient with nephroblastoma. Panel A shows a schematic illustration of the mode of action of autologous T cells transduced with a vector encoding for both the HLA-A*02:01–restricted T-cell receptor (TCR) that is specific to preferentially expressed antigen in melanoma (PRAME) and the CD8αβ coreceptor. Panel B shows a schematic overview of the timing of the patient’s treatment course after the PRAME-specific TCR infusion. Panel C shows the patient’s radiologic response in a comparison of imaging performed before treatment and at 6 months. Panel D shows the change in the diameter of respective target lesions measured. Panel E shows the metabolic response on 18F-fluorodeoxyglucose positron-emission tomography–CT (FDG PET-CT) (transverse plane). Panel F shows the results of an analysis of cfDNA in peripheral blood, plotted as the fraction of circulating tumor DNA (ctDNA) within cfDNA.
Oliver Zivanovic retweeted
The summary of a life well lived. His skills, compassion and desire to mentor those around him guided countless physicians throughout his career. What a true joy it’s been to learn from, work with and help build the department with him over the last 25+ years. A real LEGEND!
1/2 Great read from my mentor to go into urology while @bcm_urology that also influenced subsequent residency choice. Great inspiration and road map with mention of @VickersBiostats @easthamja @bbmdmsk @UrologyMSK and many others!
